StemCells Inc Share Price Nasdaq
Stocks
US85857R2040
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Market Cap | 13Cr 11Cr 10Cr 9.61Cr 18Cr 1.22TCr 18Cr 123.73Cr 48Cr 600.41Cr 48Cr 47Cr 2.07TCr | P/E 2026 * |
-6.37x | P/E 2027 * | -5.97x |
|---|---|---|---|---|---|
| Enterprise Value | 13Cr 11Cr 10Cr 9.61Cr 18Cr 1.22TCr 18Cr 123.73Cr 48Cr 600.41Cr 48Cr 47Cr 2.07TCr | EV / Sales 2026 * |
37.2x | EV / Sales 2027 * | 12.1x |
| Free-Float |
100% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: StemCells Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 54 | 02/08/1988 |
Rachel Vaknin
DFI | Director of Finance/CFO | 47 | 01/04/2022 |
Michal Ahuvia
COO | Chief Operating Officer | - | 21/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Harel Gadot
CHM | Chairman | 54 | 01/01/2013 |
Scott Burell
BRD | Director/Board Member | 61 | 28/11/2016 |
Martin Madden
BRD | Director/Board Member | 65 | 06/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.70% | +7.41% | +2.50% | +8.22% | 4.99TCr | |
| +0.92% | +3.93% | +399.71% | +605.33% | 4.02TCr | |
| +1.89% | +8.32% | +26.06% | -6.35% | 3.46TCr | |
| +2.38% | +6.35% | +21.25% | +64.58% | 3.31TCr | |
| +3.96% | +10.67% | +8.30% | +40.44% | 2.75TCr | |
| +2.51% | +5.27% | - | - | 1.7TCr | |
| +2.58% | +5.79% | +73.44% | +133.27% | 1.59TCr | |
| +0.32% | +0.58% | +14.00% | +19.59% | 1.39TCr | |
| +3.30% | +0.76% | +90.23% | +99.12% | 1.35TCr | |
| Average | +2.17% | +5.82% | +79.44% | +120.52% | 2.73TCr | |
| Weighted average by Cap. | +2.07% | +6.53% | +90.20% | +137.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 34.5L 30.16L 27.72L 25.84L 49L 33Cr 49.75L 3.33Cr 1.29Cr 16Cr 1.29Cr 1.27Cr 56Cr | 1.06Cr 92.67L 85.16L 79.38L 1.51Cr 100.93Cr 1.53Cr 10Cr 3.97Cr 50Cr 3.98Cr 3.89Cr 170.96Cr |
| Net income | -2.04Cr -1.79Cr -1.64Cr -1.53Cr -2.9Cr -194.71Cr -2.95Cr -20Cr -7.67Cr -96Cr -7.68Cr -7.51Cr -329.82Cr | -2.14Cr -1.88Cr -1.72Cr -1.61Cr -3.05Cr -204.23Cr -3.09Cr -21Cr -8.04Cr -100.39Cr -8.05Cr -7.88Cr -345.94Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
